ONCE-WEEKLY BASAL INSULIN FC (BIF) DEMONSTRATED SIMILAR GLYCEMIC CONTROL TO ONCE-DAILY INSULIN DEGLUDEC (DEG) IN INSULIN-NAIVE PATIENTS WITH TYPE 2 DIABETES (T2D)

被引：0
|
作者：
Bue-Valleskey, J. [1 ]
Kazda, C. [1 ]
Ma, C. [1 ]
Chien, J. [1 ]
Zhang, Q. [1 ]
Chigutsa, E. [1 ]
Landschulz, W. [1 ]
Swan, J. [1 ]
Haupt, A. [1 ]
Frias, J. P. [2 ]
机构：
[1] Eli Lilly & Co, Global Sci Commun, Indianapolis, IN USA
[2] Veloc Clin Res, Los Angeles, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
620
引用
收藏
页码：A193 / A193
页数：1
相关论文
共 50 条
  • [41] Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 diabetes mellitus: Once-daily basal insulin or twice-daily premixed insulin?
    Sun, Peter
    Wang, Ruoping
    Jacober, Scott J.
    DIABETES, 2006, 55 : A101 - A101
  • [42] Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naive Patients with Type 2 Diabetes: A Randomized Controlled Trial
    Kumar, Ajay
    Franek, Edward
    Wise, Jonathan
    Niemeyer, Marcus
    Mersebach, Henriette
    Simo, Rafael
    PLOS ONE, 2016, 11 (10):
  • [43] Once-daily insulin detemir in a cohort of insulin-naive patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
    Meneghini, L. F.
    Dornhorst, A.
    Sreenan, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 1029 - 1035
  • [44] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Shah, Viral N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08):
  • [45] Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study
    Kazda, Christof M.
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Wullenweber, Paula
    Haupt, Axel
    Frias, Juan P.
    DIABETES, 2021, 70
  • [46] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Rosenstock, Julio
    Bajaj, Harpreet S.
    Janez, Andrej
    Silver, Robert
    Begtrup, Kamilla
    Hansen, Melissa V.
    Jia, Ting
    Goldenberg, Ronald
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2107 - 2116
  • [47] Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
    Watada, Hirotaka
    Asbjornsdottir, Bjorg
    Nishida, Tomoyuki
    Nishimura, Rimei
    Yamamoto, Yuiko
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5882 - 5895
  • [48] Impact of age on the efficacy and safety of once-weekly insulin icodec vs once-daily insulin in type 2 diabetes: ONWARDS 1-5
    Vianna, A. G. D.
    Desouza, C.
    Laugesen, C.
    Fragao-Marques, M.
    Nielsen, P. H.
    Shaikh, S.
    Lingvay, I.
    DIABETOLOGIA, 2024, 67 : S376 - S376
  • [49] Similar hypoglycaemia duration with once-weekly insulin icodec vs insulin glargine U100 in insulin naive or experienced patients with type 2 diabetes
    Silver, R.
    Asong, M.
    Begtrup, K.
    Heller, S. R.
    Liu, L.
    Rosenstock, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 73 - 73
  • [50] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
12345